Task B1: Phase I Clinical Trial of a Therapeutic for Gram Negative and Positive Bacteria Infection

任务 B1：革兰氏阴性和阳性细菌感染治疗方法的 I 期临床试验

• 批准号: 10834715
• 负责人: GRAIG SHOCKEY
• 金额: $ 23.89万
• 依托单位: DYNPORT VACCINE COMPANY, LLC
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-13 至 2023-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10834715
• 关键词: Bacteria; Bacterial Drug Resistance; Bacterial Infections; Clinical Trials Unit; Investigation; Phase I Clinical Trials; Therapeutic; Therapeutic Agents; infectious disease treatment; novel therapeutics

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.

I期临床试验单位为研究治疗传染病的新治疗剂提供了载体。